Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 944,959 | 832,059 | 942,029 | 925,359 | 876,411 |
| Cost of Goods | 219,958 | 208,563 | 240,787 | 234,132 | 230,216 |
| Gross Profit | 725,001 | 623,496 | 701,242 | 691,227 | 646,195 |
| Operating Expenses | 583,118 | 588,065 | 528,097 | 530,753 | 557,854 |
| Operating Income | 142,841 | 35,994 | 173,932 | 160,606 | 88,557 |
| Interest Expense | 12,098 | 15,540 | 18,562 | 22,480 | 21,409 |
| Other Income | 4,509 | -1,252 | -1,041 | -3,045 | -2,361 |
| Pre-tax Income | 135,252 | 19,202 | 154,329 | 135,081 | 64,787 |
| Income Tax | 8,181 | -35,482 | 33,921 | -758 | 3,813 |
| Net Income Continuous | 127,071 | 54,684 | 120,408 | 135,839 | 60,974 |
| Net Income | $127,071 | $54,684 | $120,408 | $135,839 | $60,974 |
| EPS Basic Total Ops | 0.56 | 0.24 | 0.53 | 0.59 | 0.27 |
| EPS Basic Continuous Ops | 0.56 | 0.24 | 0.53 | 0.59 | 0.27 |
| EPS Diluted Total Ops | 0.54 | 0.23 | 0.51 | 0.58 | 0.26 |
| EPS Diluted Continuous Ops | 0.54 | 0.23 | 0.52 | 0.58 | 0.26 |
| EPS Diluted Before Non-Recurring Items | 1.20 | 0.83 | 1.21 | 1.25 | 1.07 |
| EBITDA(a) | $240,434 | $132,325 | $274,482 | $261,919 | $244,481 |